http://www.lsis.com/goto/r102/rss 2010-06-23T11:11:01+01:00 text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97f%FB%1Cuz%7D DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International (NYSE:BAX), will host a quarterly conference call to discuss its second quarter 2010 financial results on Thursday, July 22, 2010 at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-261-7280 (domestic) or 703-639-1228 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you. This call is being webcast by Thomson/CCBN and can be accessed at Baxter s Web site at http:/www.baxter.com/. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter s permission. The (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v102/%3B%97f%FD%11xv%7F ROCKVILLE, MD-(Marketwire - June 14, 2010) - MarketResearch.com has announced the addition of Kalorama Information's new report "The Global Market for Medical Devices," to their collection of Medical Devices market reports. For more information, visit http:/www.marketresearch.com/product/display.asp?ProductID=2592223. The medical device market is vast and everything from a large imaging system to a disposable item can be classified as a type of medical device. Throughout the past decade, Kalorama has covered many device markets in detail. Certain areas such as infusion pumps, patient monitoring and catheters have shown promising growth. Others have solid market leaders earning stable (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97f%FD%11%7E%7Dy DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/b2fd5c/medical_devices_ma) has announced the addition of the "Medical Devices Market in China 2009-2013" report to their offering. Medical devices comprise surgical equipment & appliances, diagnostic devices, X-ray, ophthalmic equipment, laboratory devices & diagnostics, dental equipment, medical disposables and others. The Chinese Medical devices industry is experiencing healthcare reforms leading to improvisation and increase in demand for new improved medical devices. The Chinese government is taking various initiatives to provide improved and sustainable healthcare to its citizen by expanding its (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97f%FD%11%7Dx%7D SAN JOSE, Calif.-(BUSINESS WIRE)-Alverix, Inc., a leader in developing next generation instrument and connectivity platforms for diagnostic testing, today announced that Richard œRic  C. Tarbox, III has been named Chief Executive Officer of the company. Mr. Tarbox has more than 30 years of experience in the healthcare industry, with a proven global track record within the diagnostic and medical device segments. He joins Alverix having previously served as VP, Strategy Management at Cardinal Health, Inc. (NYSE: CAH - News), a $96 billion health care services company that improves the cost-effectiveness of health care, helping pharmacies, hospitals and ambulatory care sites focus on (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97f%FE%12%7Dy%7E DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/4858e8/financial_analysis) has announced the addition of the "Financial Analysis - Baxter International" company profile to their offering. Business scenario in today's context - niche opportunities, limited time periods, ever increasing risk and the need for precise decision making, which if not done correctly would run the costs in million even before brakes are exercised. That is the speed of business in today's high octane economies which are constantly metamorphosing into global empires of influence. Even the best decision makers have made mistakes which have wiped out entire reserves built over (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97f%FE%12%7Cyz WASHINGTON-(BUSINESS WIRE)-In a massive effort to ignite a passion for science and engineering in middle and high school students, the USA Science & Engineering Festival will send more than fifty top scientists and engineers into local schools this October 10-24, 2010. The hope is that meeting scientists and engineers who love what they do, will help students embrace these disciplines and consider careers in them. The Nifty Fifty, as they are called, were carefully chosen from hundreds of applicants for their differing fields, talents, divergent backgrounds and ages, and ability to convey the importance of science to our nation s future. Supported by festival host Lockheed Martin and (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97f%FE%14%7C%7Ex DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE: BAX) announced today that it will present at the William Blair 30th Annual Growth Stock Conference on Thursday, June 17, 2010 at 8:40 a.m. (CT). text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97f%FE%15tzz DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE: BAX) announced today that it will present at the Goldman Sachs 31st Annual Global Healthcare Conference on Wednesday, June 16, 2010 at 8:00 a.m. (PT) or 10:00 a.m. (CT). text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97f%FE%15x%7Cz DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE: BAX) announced today that it will present at the Goldman Sachs 31st Annual Global Healthcare Conference on Wednesday, June 16, 2010 at 8:00 a.m. (PT) or 10:00 a.m. (CT). The live webcast of Baxter's presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through July 16, 2010. Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97f%FF%15tw%7C DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/4fe20c/global_dialysis_ma) has announced the addition of the "Global Dialysis Market Report: 2010 Edition" report to their offering. Dialysis is a process by which salt, fluid and toxins are removed artificially to clean the blood of ESRD patients. End stage renal disease (ESRD) is a stage of chronic kidney disease (CKD) which requires dialysis treatments. The dialysis market is divided into two segments namely dialysis product segment and dialysis services (care) segment. The dialysis care segment provides the services while the dialysis products segment provides all the related equipments and (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97f%FF%15tv%7B DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/f8bc26/option_and_evaluat) has announced the addition of the "Option and Evaluation Agreements in Pharma and Biotech, 2nd Edition" report to their offering. Option and Evaluation Agreements in Pharma and Biotech, 2nd Edition The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. This report provides details of the latest option and evaluation agreements announced in the pharmaceutical and biotechnology sectors. Detailed and (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F6%12%7Ev%7F DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/ed89f5/a_decision_support) has announced the addition of the "A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market" report to their offering. A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market This report comprises defined and up to date development strategies for 346 prostate cancer drugs within the portfolio of 198 investigators, from Ceased to Marketed. The report extensively analyses 202 identified targets of prostate cancer drugs, organized into 187 drug target strategies, and (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97g%F6%10zv%7B DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE:BAX) announced today two executive changes. Robert M. Davis, has been appointed corporate vice president and president of Baxter s Renal business, filling a role vacated by Bruce H. McGillivray, who is retiring after 30 years of service to the company. text/html http://www.bionity.com Bionity.com http://www.lsis.com/goto/v102/%3B%97g%F6%10yzy 02.06.2010 - Kuros Biosurgery AG announced that it has completed recruitment in a 200 patient Phase IIb clinical trial designed to assess the efficacy and safety of KUR-113 (Viz.I-040202) in open tibial shaft fractures. This study is a randomized, controlled, open-label (dose-blinded) dose finding study of the safety and efficacy of KUR-113 in the treatment of patients with acute open tibial shaft fractures. The aim of the trial is to assess the safety and efficacy of KUR-113 in combination with standard of care (SOC) vs SOC alone. The use of KUR-113 is designed to improve bone healing by reducing the time needed to achieve bone healing as well as the incidence of secondary interventions. (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F6%10%7E%7D%7D DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE:BAX) announced today two executive changes. Robert M. Davis, has been appointed corporate vice president and president of Baxter s Renal business, filling a role vacated by Bruce H. McGillivray, who is retiring after 30 years of service to the company. Davis previously served as corporate vice president and chief financial officer for Baxter. Concurrent with this change, Robert J. Hombach has been named corporate vice president and chief financial officer. Hombach previously served as corporate vice president and treasurer for Baxter. œWe are grateful for Bruce s many contributions over his 30-year career at Baxter,  said (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F7%1Dx%7Es DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/f35cd8/h1n1_vaccines_gl) has announced the addition of the "H1N1 Vaccines - Global Strategic Business Report" report to their offering. H1N1 Vaccines - Global Strategic Business Report This report analyzes the Global market for H1N1 Vaccines in US$ Million. Annual estimates and forecasts are provided for the period 2009 through 2015. The report profiles 21 companies including Baxter International, Inc., CPL Biologicals Pvt. Ltd., CSL Limited, GlaxoSmithKline Plc, MedImmune, LLC, Novartis AG, Sanofi Pasteur, SA, Simcere Pharmaceutical Group, Sinovac Biotech Ltd., Solvay SA, and Zydus Cadila. Market (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F7%1D%7Fws DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/a58de5/global_renal_dialy) has announced the addition of GlobalData's new report "Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" to their offering. Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 provides key data, information and analysis on the global renal dialysis equipment market. The (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F7%1D%7Fwz CHICAGO-(BUSINESS WIRE)-The Illinois General Assembly late yesterday passed with overwhelming bipartisan support an Angel Tax Credit that incentivizes early-stage investment in Illinois technology companies. The Governor, whose office worked hard to pass the credit, is expected to sign the bill (SB 2093) or a second measure (SB 3710) with an identical Angel Tax Credit sent to the Senate yesterday by the House. Today s most powerful job engines are small innovative firms. Yesterday Illinois took a huge step in helping to create and attract those companies Knowledgeable observers expressed certainty the program would be enacted into law this spring or in November at the latest. The (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F7%10%7Dw%7F DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/2ea526/expanding_a_produc) has announced the addition of the "Expanding a Product Portfolio Without Cannibalizing an Established Brand" report to their offering. Expanding a Product Portfolio Without Cannibalizing an Established Brand Managing multiple products for the same indication is a complex balancing act for bio-pharmaceutical companies today especially those that want to prevent one of their brands from gaining market share at the expense of another. Maximizing the potential of each product requires well-crafted marketing strategies and smart resource allocation plans. Marketers have to make (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F8%12z%7Bx DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/91188e/clinical_nutrition) has announced the addition of the "Clinical Nutrition Products - Global Strategic Business Report" report to their offering. Clinical Nutrition Products - Global Strategic Business Report This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Japan, Europe, China, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F9%17z%7Dr DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/80e6ee/pulmonary_drug_del) has announced the addition of the "Pulmonary Drug Delivery Technologies - Global Strategic Business Report" report to their offering. Pulmonary Drug Delivery Technologies - Global Strategic Business Report This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in US$ Million by the following Product Segments: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), and Others. The report provides separate comprehensive analytics for US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of the World. Annual estimates and forecasts are (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F9%17yvy ARLINGTON, Va. & DEERFIELD, Ill.-(BUSINESS WIRE)-In recognition of his contributions to the field of health services research and lifelong achievements, Uwe E. Reinhardt, Ph.D., has been named the 2010 recipient of the William B. Graham Prize for Health Services Research. The Prize, funded by The Baxter International Foundation and managed by the Association of University Programs in Health Administration (AUPHA), will be awarded on June 5, 2010, at the AUPHA Annual Meeting in Portland, Ore. Dr. Reinhardt is recognized as one of the leading U.S. authorities on healthcare economics and health policy, and is the James Madison Professor of Political Economy and Professor of Economics at (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F9%17yvz DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/488502/global_infusion_sy) has announced the addition of GlobalData's new report "Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" to their offering. Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 provides key data, information and analysis on the global infusion systems market. The report provides market landscape, competitive landscape and market trends information the infusion systems market. The report provides (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%F9%14t%7F%7B MENLO PARK, Calif.-(BUSINESS WIRE)-IncellDx is pleased to announce the addition of Brandon Steele to their Senior Management Team as Vice President of Commercial Operations. We are delighted to have Brandon join our team. With over 20 years of experience in sales, marketing, and management in the healthcare industry he will develop and accelerate our overall commercialization efforts including new business alliances In this position, he will be responsible for developing and executing the commercialization plan for the HPV OncoTect E6, E7 mRNA test among other products. The HPV OncoTect test provides quantification of the overexpression of E6/E7 mRNA in each cell, as well as the total (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97g%FA%12t%7Fx DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE: BAX) announced today that it will present at the 2010 Citi Investment Research Global Health Care Conference on Wednesday, May 26, 2010 at 10:00 a.m. (ET) or 9:00 a.m. (CT). text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FA%12xvz LA JOLLA, Calif.-(BUSINESS WIRE)-The Board of Trustees of the Salk Institute for Biological Studies unanimously voted to elect four new members with records of extraordinary entrepreneurial success and expertise in business, innovation, real estate and philanthropy. These four individuals exemplify uniquely American success stories of innovation, entrepreneurial acumen and the desire to give back to their communities and the world œThese four individuals exemplify uniquely American success stories of innovation, entrepreneurial acumen and the desire to give back to their communities and the world,  said Salk Board Chairman Irwin M. Jacobs. œI am confident that their considerable (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FA%12x%7F%7B DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE: BAX) announced today that it will present at the 2010 Citi Investment Research Global Health Care Conference on Wednesday, May 26, 2010 at 10:00 a.m. (ET) or 9:00 a.m. (CT). The live webcast of Baxter's presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through June 26, 2010. Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FA%12x%7E%7D DUBLIN-(BUSINESS WIRE)-Maven Semantic (http:/www.mavensemantic.com) announces updates to their diabetes research database. , based on where they work, their job title, how many times they have published, where they have published, etc. The relevance can be fine tuned by the user The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector. This dataset will also be relevant to those working in the area of drug delivery technologies, and to companies that supply labs involved in respiratory drug development. The database currently tags 202,240 individuals working in diabetes (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FA%17zvr DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE:BAX) announced today that a voluntary recall of all manufactured lots of HYLENEX recombinant (hyaluronidase human injection) has been initiated as a precautionary measure due to instances of particulate matter observed in a limited number of HYLENEX vials during routine stability testing. Baxter is working with the product s NDA-holder, Halozyme Therapeutics, to investigate the root cause of the issue and appropriately address the situation. To date, no medical events or customer complaints associated with this issue have been reported. Baxter and Halozyme are committed to quickly and appropriately addressing the situation. (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97g%FA%17y%7F%7E DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE:BAX) announced today that a voluntary recall of all manufactured lots of HYLENEX recombinant (hyaluronidase human injection) has been initiated as a precautionary measure due to instances of particulate matter observed in a limited number of HYLENEX vials during routine stability testing. Baxter is working with the product s NDA-holder, Halozyme Therapeutics, to investigate the root cause of the issue and appropriately address the situation. text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FC%16z%7Ex HOUSTON-(BUSINESS WIRE)-Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI) announced that the Company has just executed an option with Stand-By Systems, owner of the FDA approved SBS 1615 catalytic oxygen generator and other FDA approved breakthrough emergency portable oxygen systems and devices. The SBS 1615 catalytic oxygen generator provides medical grade USP oxygen at the push of a button from self-contained inert dry compounds. Stand-By Systems intends to make this portable personal life-saving device (smaller than the size of a soft drink can) become as common in everyday life as first-aid kits, household fire extinguishers and smoke detectors. The potential market for these (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FD%13y%7Bs DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE: BAX) announced today that it will present at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 11, 2010 at 9:20 a.m. (ET) or 8:20 a.m. (CT). The live webcast of Baxter's presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through June 10, 2010. Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FD%13xx%7C DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/77f357/baxter_internation) has announced the addition of the "Baxter International Inc-Detailed Product Pipeline" company profile to their offering. Baxter International Inc-Detailed Product Pipeline contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope of the reports - Pipeline Report provides the user with real detail on a company's pipeline. In addition to business summaries, contact information, company details and selected financial data, each report also (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97g%FD%11%7Cyz DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE: BAX) announced today that it will present at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 11, 2010 at 9:20 a.m. (ET) or 8:20 a.m. (CT). text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97g%FD%15xvs DALLAS-(BUSINESS WIRE)-Bone Solutions Inc. ( œBSI ) announced today that it will soon file four additional 510(k) applications with the FDA related to its OsteoCrete ¢ platform. The Company has previously received FDA 510(k) clearance for the first application in its OsteoCrete ¢ pipeline as a proprietary bone void filler. These imminent additional FDA filings will empower BSI to explore major new strategic partnerships within the orthopedic industry. OsteoCrete ¢ was certified in May 2009 as a bone void filler by the FDA for broad applications in musculoskeletal structure, trauma, bone grafting, and related surgeries. BSI is next filing for 510(k) certification for maxillofacial (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97g%FD%15xxx DEERFIELD, Ill.-(BUSINESS WIRE)-The Board of Directors of Baxter International Inc. (NYSE:BAX) today announced a quarterly dividend and the results of votes taken at the company s Annual Meeting of Shareholders held earlier today. text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FE%1Cuv%7B DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter Healthcare Corporation today announced that it will recall COLLEAGUE infusion pumps from the U.S. market pursuant to an order under its existing June 2006 consent decree with the U.S. Food and Drug Administration (FDA). Baxter will work with the FDA to ensure that the recall process provides customers appropriate alternatives for supporting patients needs. As previously disclosed, Baxter entered into a consent decree with FDA under which the company has been pursuing remediation of the infusion pumps. The decree permits FDA to require the recall of the pumps, and FDA has communicated to the company that it will require such a recall, with the (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FE%1Cu%7B%7B DEERFIELD, Ill.-(BUSINESS WIRE)-The Board of Directors of Baxter International Inc. (NYSE:BAX) today announced a quarterly dividend and the results of votes taken at the company s Annual Meeting of Shareholders held earlier today. Baxter s Board of Directors declared a quarterly dividend of $0.29 per share of Baxter common stock. This payment represents a continuation of the current rate, which the company increased 12 percent earlier this year. The quarterly dividend is payable on July 1, 2010 to shareholders of record as of June 10, 2010. At its Annual Meeting of Shareholders held today, Baxter shareholders re-elected four members of the company s Board of Directors Blake E. Devitt, (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97g%FE%10%7Dv%7F DEERFIELD, Ill., May 03, 2010 (BUSINESS WIRE) - Baxter Healthcare Corporation today announced that it will recall COLLEAGUE infusion pumps from the U.S. market pursuant to an order under its existing June 2006 consent decree with the U.S. Food and Drug Administration (FDA). Baxter will work with the FDA to ensure that the recall process provides customers appropriate alternatives for supporting patients' needs. As previously disclosed, Baxter entered into a consent decree with FDA under which the company has been pursuing remediation of the infusion pumps. The decree permits FDA to require the recall of the pumps, and FDA has communicated to the company that it will require such a recall, (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v102/%3B%97g%FE%14%7Cw%7C JOHANNESBURG, SOUTH AFRICA-(Marketwire - April 30, 2010) - www.rothmanresearch.com - The medical instrument and supplies industry in the U.S. and globally has a promising future as more and more surgeries are being performed due to the appearance of state-of-the-art technologies which promote less invasive surgical treatments. It is believed that over 15 million people have surgeries in the U.S. annually, and that this trend will be on the rise supported by the aging population and baby boomer demographic. "Plastic surgery is one of the growing trends in the United States, and people are eagerly considering these kinds of surgeries because new technologies help minimize a big (…) text/html http://www.medicalnewstoday.com Medical News Today http://www.lsis.com/goto/v102/%3B%97g%FE%14%7C%7E%7E Next week, Chicago will host the 2010 Biotechnology Industry Organization (BIO) International Convention, where an estimated 15,000 global industry leaders will come together to address many of the most pressing health, food and energy challenges facing our world today. As co-sponsor of this year's convention, which takes place May 3-6 at McCormick Place, Baxter International Inc. is pleased to welcome the biotech community to the Midwest, and to the company's home state of Illinois, which has long been a hub for groundbreaking biotechnology research and development, thanks to several world-renowned academic, government and non-profit research institutions. In 2008, for example, Illinois (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97g%FF%16t%7Cs DEERFIELD, Ill.-(BUSINESS WIRE)-Next week, Chicago will host the 2010 Biotechnology Industry Organization (BIO) International Convention, where an estimated 15,000 global industry leaders will come together to address many of the most pressing health, food and energy challenges facing our world today. As co-sponsor of this year s convention, which takes place May 3-6 at McCormick Place, Baxter International Inc. is pleased to welcome the biotech community to the Midwest, and to the company s home state of Illinois, which has long been a hub for groundbreaking biotechnology research and development, thanks to several world-renowned academic, government and non-profit research (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97%60%F8%16%7Bzy CHICAGO-(BUSINESS WIRE)-Illinois Governor Pat Quinn and Chicago Mayor Richard M. Daley joined Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood, Baxter International Inc. Chairman and CEO Robert Parkinson, Jr. and Dave Miller, president and CEO of the Illinois Biotechnology Industry Organization (iBIO) to preview the 2010 BIO International Convention, the global event for biotechnology, and to comment on Illinois biotechnology community. The BIO International Convention runs May 3 to 6 at McCormick Place in Chicago and is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau, and (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97%60%FA%1Cz%7B%7F CHICAGO-(BUSINESS WIRE)-Illinois Governor Pat Quinn and Chicago Mayor Richard M. Daley joined Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood, Baxter International Inc. Chairman and CEO Robert Parkinson, Jr. and Dave Miller, president and CEO of the Illinois Biotechnology Industry Organization (iBIO) to preview the 2010 BIO International Convention, the global event for biotechnology, and to comment on Illinois biotechnology community. The BIO International Convention runs May 3 to 6 at McCormick Place in Chicago and is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau, and (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97%60%FA%1C%7Fyr DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE:BAX) today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter s first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation. On an adjusted basis, excluding the special item, Baxter s net income of $564 million increased 9 (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97%60%FD%1C%7D%7D%7E DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE:BAX) today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter s first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation. text/html http://www.medicalnewstoday.com Medical News Today http://www.lsis.com/goto/v102/%3B%97%60%FE%15%7C%7D%7F Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy. "Mesna is our second addition this month to our cancer supportive care product line, allowing Sagent's sales teams to provide customers with an expanding range of products for oncology patients," said Jeffrey M. Yordon, Sagent's chief executive officer, founder and chairman of the board. Mesna will be available in 1 mg per 10 mL multi-dose vials, offered in single packs and in packs of (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v102/%3B%97%60%FE%15%7C%7C%7C CHARLOTTE, N.C.-(BUSINESS WIRE)-With the industry deadline for the adoption of healthcare data standards rapidly approaching, participants in a Premier healthcare alliance project are seeing benefits in preparing for implementation that lay the groundwork for improved patient safety and healthcare cost reduction. don t let ˜perfect get in the way of ˜good. Keep it simple. Starting small, and with one trading partner at a time, the industry will be able to get this done, and will be able to surmount any barriers to implementation. According to healthcare provider and supplier participants in Premier s Global Location Number (GLN) Transaction program, preparing to implement the GLN can (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97%60%FF%1Dt%7D%7E SCHAUMBURG, Ill., April 19 /PRNewswire/ - Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy. "Mesna is our second addition this month to our cancer supportive care product line, allowing Sagent's sales teams to provide customers with an expanding range of products for oncology patients," said Jeffrey M. Yordon, Sagent's chief executive officer, founder and chairman of the board. Mesna will be available in 1 mg per 10 mL (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v102/%3B%97%60%FF%1D%7F%7D%7F DEERFIELD, Ill.-(BUSINESS WIRE)-Baxter International Inc. (NYSE:BAX) announced today that Ludwig Hantson, Ph.D. has been appointed corporate vice president and president, International. He will assume his new role on Monday, May 3.